Quick answer: no oral supplement currently has evidence comparable to sunscreen for preventing photoaging or prescription tretinoin for treating photoaged skin. Among popular oral “skin-aging” supplements, collagen peptides have the most direct randomized skin-outcome literature—but the evidence is contested. NAD+ precursors reliably affect NAD-related biomarkers, while direct skin outcomes remain limited. Quercetin and resveratrol have interesting biology but much weaker direct human evidence for visible skin aging.
Key takeaways
- Direct human skin outcomes matter most: wrinkle, elasticity and hydration trials answer a different question from biomarker or cell studies.
- Collagen has the largest direct supplement literature: but recent quality and funding analyses reduce confidence in the size and reliability of the effect.
- NR/NMN evidence is not direct NAD+ evidence: precursor biomarker trials cannot be transferred to a product containing the NAD+ molecule itself.
- Quercetin and resveratrol remain earlier-stage for visible skin outcomes: mechanistic plausibility should not be promoted as clinical proof.
How this ranking works
We rank evidence by how directly it answers the consumer question “does taking this improve a human skin-aging outcome?” Mechanistic plausibility is not enough.
| Tier | Meaning |
|---|---|
| A | Multiple consistent, high-quality human trials on relevant skin outcomes. |
| B | Human trials exist, but effect size, quality or consistency is debated. |
| C | Human biomarker data or limited clinical evidence; skin outcome evidence weak. |
| D | Mostly mechanistic, preclinical or extrapolated evidence. |
Evidence snapshot
| Intervention | Direct human skin outcomes | Current interpretation |
|---|---|---|
| Collagen peptides | Multiple randomized trials | Most directly studied oral category here, but quality and funding concerns matter. |
| NR / NMN | Limited for visible skin aging | Human NAD-related biomarker evidence is stronger than direct skin-outcome evidence. |
| Direct oral NAD+ | Insufficient for visible skin aging | Biologically important pathway; dedicated formulation and outcome trials are still needed. |
| Resveratrol | Limited | Promising mechanistic literature with weaker oral clinical skin evidence. |
| Quercetin | Very limited as a stand-alone skin intervention | Senescence interest is driven substantially by preclinical work and combination studies. |
#1 Collagen peptides — Tier B
Collagen peptides have numerous randomized studies measuring hydration, elasticity and wrinkles. Some pooled analyses report benefits. However, a 2025 meta-analysis found no effect in higher-quality studies or studies without pharmaceutical-company funding. That weakens certainty and makes “proven” too strong.
2025 meta-analysis on collagen supplements and skin aging.
Interpretation: the most directly studied supplement category for visible skin endpoints, but the magnitude and reliability of benefit remain debated. See Collagen vs NAD+ for a direct comparison.
#2 NAD+ precursors (NR and NMN) — Tier C for skin
NR and NMN are well studied as ways to alter NAD-related biomarkers in humans. That is meaningful human evidence for the pathway. It is not equivalent to randomized evidence that they reduce wrinkles or improve skin elasticity.
Important: PAG NAD CORE contains direct NAD+, not NR or NMN. Precursor trials cannot be used as direct efficacy evidence for PAG NAD CORE. Read NAD+ for Skin: Direct NAD+, NR and NMN Evidence Explained.
#3 Resveratrol — Tier C/D for oral skin-aging outcomes
Resveratrol has extensive mechanistic literature involving oxidative stress and cellular signaling, plus some human dermatologic research. But oral resveratrol has not established itself as a clinically proven wrinkle treatment. Skin-specific reviews generally describe the field as promising while calling for better clinical studies.
See the dedicated resveratrol evidence review.
#4 Quercetin — Tier D for visible skin aging
Quercetin is often marketed as a “natural senolytic.” The most cited human senolytic study used dasatinib plus 1,000 mg quercetin for three days in nine people with diabetic kidney disease. It observed changes in senescence markers, including in skin biopsies. That does not prove 250 mg/day quercetin alone produces the same effect in healthy skin.
Preliminary human dasatinib + quercetin study.
For the dose and combination distinction, read Quercetin, Cellular Senescence and Skin.
Where does direct oral NAD+ rank?
Direct oral NAD+ should currently be considered emerging / insufficient direct evidence for visible skin outcomes. NAD+ itself is fundamental to cell biology, but formulation pharmacokinetics and clinical outcomes must be tested rather than inferred from precursor studies.
Why we are not ranking our own formula #1
PAG LABS sells a formula containing NAD+, quercetin and Japanese knotweed extract standardized to 98% resveratrol. Ranking those ingredients above better-studied interventions simply because we sell them would undermine the purpose of an evidence library. Our commercial relationship is a reason to be more explicit about uncertainty, not less.
What actually outranks supplements for photoaging?
Regular sunscreen use has randomized human evidence for slowing measured skin aging, and topical tretinoin has systematic-review evidence from randomized trials for photoaging. Supplements should be considered in that context. For a practical hierarchy, see How to Reduce Wrinkles Naturally.
FAQ
What is the best anti-aging supplement for skin?
There is no single supplement that can be called best across all outcomes. Collagen currently has more direct randomized skin-outcome literature than the other oral categories compared here, but recent analyses raise substantial questions about study quality and funding.
Are NAD+, NR and NMN interchangeable in research?
No. They are distinct molecules or interventions. A trial of NR or NMN can inform the broader NAD pathway, but it cannot establish the pharmacokinetics or skin efficacy of direct oral NAD+.
Does mechanistic evidence count?
Yes, but it answers a narrower question: whether a pathway is biologically plausible. It does not establish that a specific dose improves wrinkles, elasticity or photoaging in humans.
Bottom line
If your standard is direct human skin outcomes, collagen peptides currently have more relevant trial data than NAD+, quercetin or resveratrol—but even collagen evidence is contested. NAD-pathway research is biologically compelling, while clinical skin translation remains an open question.
Related PAG LABS research
- Collagen vs NAD+: Which Has Better Evidence for Skin Aging?
- NAD+ for Skin: Direct NAD+, NR and NMN Evidence Explained
- Topical vs Oral Skin Aging Interventions
- PAG LABS Research Library
Last reviewed: September 2026.
This ranking evaluates evidence, not medical suitability. Discuss supplements with a healthcare professional when appropriate.